Our study elucidated the role of APOC1 in the neurodegenerative processes underlying AD, potentially confirming its use as a biomarker for early intervention in a multimodal setup spanning the gene-imaging-phenotype spectrum. Here, APOC1 is linked to Alzheimer disease.